Multi-organ toxicity metals

Cadmium is bound to proteins and red blood cells in blood and transported in this form, but 50% to 75% of the body burden is located in the liver and kidneys. The half-life of cadmium in the body is between 7 and 30 years, and it is excreted through the kidneys, particularly after they become damaged. 

This may be due to the interference with the mitochondrial electron transport chain. Thus, cadmium binds to complex III at the Q0 site between semi-ubiquinone and heme b566. This stops delivery of electrons to the heme and allows accumulation of semi-ubiquinone, which in turn transfers the electrons to oxygen and produces superoxide. 

However, in vitro studies in hepatoma cells showed that lysosmal damage precedes the DNA and mitochondrial damage. 

There seems to be a critical level of cadmium in the kidney when the kidney metallothionein is saturated and the free cadmium causes toxicity. The damage to the kidney occurs in the first and second segments of the proximal tubule. This can be detected biochemically as glucose, amino acids, and protein in urine. The proteins are predominantly of 

The binding of cadmium to metallothionein decreases toxicity to the testes but increases the nephrotoxicity, possibly because the complex is preferentially, and more easily, taken up by the kidney than the free metal. Dosing animals with the cadmium-metallothionein complex leads to acute kidney damage, whereas exposure to single doses of cadmium itself does not. 

---

Thus, cadmium causes multi-organ toxicity, and at least some of the toxic effects are due to it being a divalent metal similar to zinc and able to bind to sulfydryl groups. 

Lead is a toxic metal to which there is wide exposure. Exposure is via inhalation (main source, leaded petrol) and ingestion (water, old paint). Multi-organ toxicity occurs with the kidneys, central and peripheral nervous system, testes, red cells, bones, and gastrointestinal tract all damaged. After initial distribution into red blood cells, it is eventually deposited in bone. The main biochemical effect is interference with heme synthesis at several points. Kidney toxicity may be due to lead-protein complexes and inhibition of mitochondrial function. Damage to nerves leads to peripheral neuropathy. 

In modern practice, inhibitors are rarely used in the form of single compounds — particularly in near-neutral solutions. It is much more usual for formulations made up from two, three or more inhibitors to be employed. Three factors are responsible for this approach. Firstly, because individual inhibitors are effective with only a limited number of metals the protection of multi-metal systems requires the presence of more than one inhibitor. (Toxicity and pollution considerations frequently prevent the use of chromates as universal inhibitors.) Secondly, because of the separate advantages possessed by inhibitors of the anodic and cathodic types it is sometimes of benefit to use a formulation composed of examples from each type. This procedure often results in improved protection above that given by either type alone and makes it possible to use lower inhibitor concentrations. The third factor relates to the use of halide ions to improve the action of organic inhibitors in acid solutions. The halides are not, strictly speaking, acting as inhibitors in this sense, and their function is to assist in the adsorption of the inhibitor on to the metal surface. The second and third of these methods are often referred to as synergised treatments. 

Unfortunately, multi-step coating technologies produce wastes including organic solvents, heavy metals, and other toxic and deleterious materials (4). 

---